Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Octreotide Article
This is a selection made from among articles on Drug Treatment Octreotide. For a permanent link to this article, or to bookmark it for future reading, click here.
Alcohol Treatment Therapy in California
from:by David Richards
California is often thought of as the leader in innovation solutions to both modern and historically problems. When it comes to treatment for alcoholism this tradition continues. They are in the forefront of developing cutting edge alcohol treatment therapy programs that are being adopted around the world to help curb addiction.Alcoholism known no age or class boundaries; everyone from children to senior citizens from all walks of life can be affected. Through innovative substance abuse programs such as specialized camps, licensed therapists and peer support groups many people are finding getting treatment for their addiction is easier and more supporting than ever before. Many people do not seek treatment for alcohol abuse because of concerns over the perception associated with attending many of the traditional abuse programs offered around the country. With these new addiction treatment programs it is now being looked up by many as the "right thing to do" and a "sign of strength" to be enrolled in such a support group.One of the more innovative programs introduced within the last few years is camps and treatment ranches where those seeking treatment go to be around licensed professionals who can help people identify their addiction and find ways to solve it. The programs combine traditional alcohol abuse treatment with relaxation and group-building exercises such as horseback riding, hiking and in some cases relieving the stress associated with breaking the addiction by taking that stress and turn it into good by building houses for low-income households.Alcoholism affects everyone in some way or another - either directly or indirectly by being a family member, co-worker or spouse of the person with the addiction. With new programs and positive reinforcement more people are beginning to seek treatment to help build a better future.
David Richards is a writer and internet publisher who likes to write about alcoholism treatment and self help issues in general. Check out his news and in depth information website 1st-alcoholism-treatment.com
Drug Treatment Octreotide Specific links
Drug Treatment Octreotide News
Bestellen Sie den kostenlosen Newsletter von 4investors:
Novartis International AG / Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly . Processed and transmitted by Thomson Reuters ONE.
Read more...PRESS RELEASE: Novartis drug pasireotide LAR -3-
-1 of 3- 07 May 2012 05:16:00 UTC PRESS RELEASE: Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly Novartis ...
Read more...Novartis Scores in Phase III Study
Novartis announced positive results from a phase III study of pasireotide LAR
Read more...PRESS RELEASE: Novartis drug pasireotide LAR -2-
-1 of 3- 07 May 2012 05:16:00 UTC PRESS RELEASE: Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly Novartis ...
Read more...PRESS RELEASE: Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial ...
-1 of 3- 07 May 2012 05:16:00 UTC PRESS RELEASE: Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly Novartis ...
Read more...Novartis Scores in Phase III Study - Analyst Blog
Switzerland-based pharmaceutical company, Novartis AG ( NVS ) announced positive results from a phase III study of pasireotide (SOM230) long-acting release (LAR). Results from the trial
Read more...Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients ...
Novartis International AG / Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible …
Read more...